Literature DB >> 16707882

Epidemiology of psoriasis. Review and the German perspective.

Torsten Schäfer1.   

Abstract

According to population-based European studies, 2-3% of the population are affected by psoriasis. However, commonly accepted and validated diagnostic criteria are lacking. Psoriasis patients, compared to those with other dermatological disorders, are among those who suffer the highest impact on their quality of life, and this affection is comparable to other common diseases. Several lifestyle factors including alcohol and smoking have been associated with psoriasis. There is also evidence for associations with other diseases including cancer. Treatment of psoriasis engenders considerable costs, which should always be taken into account together with the relevant clinical outcome parameters. Prevention of psoriasis is crucial, as in the case of other common chronic diseases where causative treatments are lacking, but has barely been studied. 2006 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2006        PMID: 16707882     DOI: 10.1159/000092283

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  26 in total

Review 1.  Clinical and histologic diagnostic guidelines for psoriasis: a critical review.

Authors:  Mary Ann N Johnson; April W Armstrong
Journal:  Clin Rev Allergy Immunol       Date:  2013-04       Impact factor: 8.667

2.  Sleep Quality and its Association with Disease Severity in Psoriasis.

Authors:  Mehmet Melikoglu
Journal:  Eurasian J Med       Date:  2017-06

3.  The relation between different dimensions of alcohol consumption and burden of disease: an overview.

Authors:  Jürgen Rehm; Dolly Baliunas; Guilherme L G Borges; Kathryn Graham; Hyacinth Irving; Tara Kehoe; Charles D Parry; Jayadeep Patra; Svetlana Popova; Vladimir Poznyak; Michael Roerecke; Robin Room; Andriy V Samokhvalov; Benjamin Taylor
Journal:  Addiction       Date:  2010-03-15       Impact factor: 6.526

4.  [Psychosocial factors in psoriasis. A pilot study].

Authors:  J A Bahmer; F Petermann; J Kuhl
Journal:  Hautarzt       Date:  2007-11       Impact factor: 0.751

5.  Variable selection and prediction in biased samples with censored outcomes.

Authors:  Ying Wu; Richard J Cook
Journal:  Lifetime Data Anal       Date:  2017-02-18       Impact factor: 1.588

Review 6.  Secukinumab: A New Treatment Option for Psoriatic Arthritis.

Authors:  Philip Mease; Iain B McInnes
Journal:  Rheumatol Ther       Date:  2016-04-23

7.  IL12B and IL23R gene SNPs in Japanese psoriasis.

Authors:  Akira Oka; Tomotaka Mabuchi; Shigaku Ikeda; Tadashi Terui; Yuko Haida; Akira Ozawa; Keisuke Yatsu; Jerzy K Kulski; Hidetoshi Inoko
Journal:  Immunogenetics       Date:  2013-08-17       Impact factor: 2.846

8.  Psoriasis is an independent predictor of increased risk of allergic reaction during percutaneous coronary interventions. Big data analysis from the Polish National PCI Registry (ORPKI).

Authors:  Zbigniew Siudak; Kalina Wysocka-Dubielecka; Krzysztof Malinowski; Artur Dziewierz; Tomasz Tokarek; Krzysztof Plens; Dariusz Dudek
Journal:  Cardiol J       Date:  2018-08-29       Impact factor: 2.737

Review 9.  [Psoriasis in childhood and adolescence: clinical features and therapy].

Authors:  S Benoit; H Hamm
Journal:  Hautarzt       Date:  2009-02       Impact factor: 0.751

Review 10.  Evaluating Risk Tolerance from a Systematic Review of Preferences: The Case of Patients with Psoriasis.

Authors:  Juan Marcos Gonzalez
Journal:  Patient       Date:  2018-06       Impact factor: 3.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.